Details for: TEVA-LENOLTEC
Company: TEVA CANADA LIMITED
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 00653241 | TEVA-LENOLTEC NO. 2 | ACETAMINOPHEN; CAFFEINE; CODEINE PHOSPHATE | 300 MG; 15 MG; 15 MG | TABLET | ORAL |
| 00653276 | TEVA-LENOLTEC NO. 3 | CAFFEINE; CODEINE PHOSPHATE; ACETAMINOPHEN | 15 MG; 30 MG; 300 MG | TABLET | ORAL |
| 00621463 | TEVA-LENOLTEC NO. 4 | ACETAMINOPHEN; CODEINE PHOSPHATE | 300 MG; 60 MG | TABLET | ORAL |
Summary Reports
Summary Safety Review - Codeine-containing products - Further Assessing the Risk of Serious Breathing Problems in Children and Adolescents
Summary Safety Review - Acetaminophen - Liver Injury
Summary Safety Review - Acetaminophen - Liver Injury
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.